Up-to-date List of Pirarubicin Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Pirarubicin Medical Research Studies

RankStatusStudy
1 Recruiting CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
Conditions: ALK-negative Anaplastic Large Cell Lymphoma;   Peripherial T Cell Lymphoma,Not Otherwise Specified;   Angioimmunoblastic T Cell Lymphoma;   Enteropathy Associated T Cell Lymphoma;   Hepatosplenic T Cell Lymphoma;   Subcutaneous Panniculitis Like T Cell Lymphoma
Interventions: Drug: Cyclophosphamide 750mg/m2;   Drug: Vincristine 1.4mg/m2;   Drug: Doxorubicin 50mg/m2;   Drug: prednisone 60mg/m2;   Drug: ifosfamide 2000mg/m2;   Drug: Pirarubicin 50mg/m2;   Drug: Pirarubicin 25mg/m2;   Drug: Etoposide phosphate 100mg/m2;   Drug: methotrexate 1500mg/m2
Outcome Measures: complete remission rate;   3-year PFS;   overall response rate;   3-year os
2 Unknown  Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib,Pirarubicin,Dexamethasone;   Drug: Thalidomide,Pirarubicin,Dexamethasone
Outcome Measures: The overall response rate of PAD and TAD in patients with MM assessed by International Myeloma Working Group(IMWG) criteria;   The concentrations of bone metabolites;   chromosome examination by cytogenetic and interphase Fluorescence in situ hybridization(FISH) method;   Overall survival(OS) and progression-free survival(FPS);   European Organisation for Research and Treatment of Cancer Quality Of life-Questionnaires-C30 (EORTC QLQ-C30)
3 Unknown  Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
Condition: Lymphoblastic Leukemia, Acute
Interventions: Drug: Methotrexate;   Drug: Prednisolone;   Drug: Dexamethasone;   Drug: Vincristine;   Drug: Pirarubicin;   Drug: Cyclophosphamide;   Drug: L-asparaginase;   Drug: Cytarabine;   Drug: Hydrocortisone;   Drug: Mercaptopurine
Outcome Measures: Disease-free survival;   The rate of complete remission

These studies may lead to new treatments and are adding insight into Pirarubicin etiology and treatment.

A major focus of Pirarubicin research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Pirarubicin

© Copyright 2019.

If you think you may have a medical emergency, call your doctor or 911 immediately.

By accessing this website, you are indicating your acknowledgement and acceptance of these Terms of Use. These Terms of Use are subject to change by WinFirst LLC at any time in its discretion. Your use of WinFirst LLC Site after such changes are implemented constitutes your acknowledgement and acceptance of the changes. Please consult these Terms of Use regularly. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.

Privacy | Terms | Contact us

privacy policy